Argonaute-based programmable RNase as a tool for cleavage of highly-structured RNA
Dayeh DM, Cantara WA, Kitzrow JP, Musier-Forsyth K, Nakanishi K. Nucleic Acids Res. 2018 Jun 12. PubMed
MBNL splicing activity depends on RNA binding site structural context
Taylor K, Sznajder LJ, Cywoniuk P, Thomas JD, Swanson MS, Sobczak K. Nucleic Acids Res. 2018 Jun 28. PubMed
SRB-2: a promiscuous rainbow aptamer for live-cell RNA imaging
Sunbul M, Jäschke A. Nucleic Acids Res. 2018 Jun 21. PubMed
GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics
Springer AD, Dowdy SF. Nucleic Acid Ther. 2018 Jun;28(3):109-118. PubMed
Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility
Kulkarni JA, Cullis PR, van der Meel R. Nucleic Acid Ther. 2018 Jun;28(3):146-157. PubMed
Current Status of Messenger RNA Delivery Systems
Stanton MG. Nucleic Acid Ther. 2018 Jun;28(3):158-165. PubMed
Intracellular Trafficking and Endosomal Release of Oligonucleotides: What We Know and What We Don’t
Juliano RL. Nucleic Acid Ther. 2018 Jun;28(3):166-177. PubMed
Aptamer-Mediated Delivery and Cell-Targeting Aptamers: Room for Improvement
Yan AC, Levy M. Nucleic Acid Ther. 2018 Jun;28(3):194-199. PubMed
Circular RNAs in Cancer – Lessons Learned From microRNAs
Dragomir M, Calin GA. Front Oncol. 2018 May 28;8:179. PubMed
A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing
Finn JD, Smith AR, Patel MC, Shaw L, Youniss MR, van Heteren J, Dirstine T, Ciullo C, Lescarbeau R, Seitzer J, Shah RR, Shah A, Ling D, Growe J, Pink M, Rohde E, Wood KM, Salomon WE, Harrington WF, Dombrowski C, Strapps WR, Chang Y, ...